Support Promote Advocate

for Borderline Personality Disorder

Pick your state

Select your state for a full breakdown on your area


Q: Who can join?  Answer

Q: I think I (or someone I know) may have BPD.  Where do I go for help? 

General information about accessing treament may be found in the Treatment for BPD menu above or in the Resources tab - Support for.....

Information relevant to each state may be found by clicking on your state on the map of Australia image to the left.

Follow us on facebook

BBC Three
"In a survey by the Mental Health Foundation 32% of patients said the system missed opportunities to help at an early stage, before things go worse."
... See moreSee less

"It doesn't feel like I'm ever going to get better." 23-year-old Sophie on experiencing borderline personality disorder. #MHAW17.

Posted 1 day ago

Borderline Personality Disorder: A New Way Forward: a presentation by Professor Kulkarni at the recent MHPN BPD Network meeting.

BPD is a serious, often chronic and highly prevalent (5.9%) psychiatric disorder. The core features of BPD are dissociation, mood lability, self-harm, anger, and problems with self-identity. A common antecedent for many women with this condition is early life trauma. Current psychological treatments are expensive and difficult for patients to access, whilst no clearly designated pharmacotherapy is known to be specifically effective to treat BPD. Therefore, there is an urgent need for a new approach to this disorder.

The noted correlation of high rates of polycystic ovarian syndrome in women with BPD appears to be related to dysregulation of both the HPG and HPA axes.
The glutamatergic system, in the CNS, particularly, the N-methyl-D-aspartic acid (NMDA) subtype receptor, is increasingly recognised for its role in BPD, with recent neurobiological research linking stress, immune system alterations and neuroendocrine dysregulation observed in BPD with glutamate excitotoxicity.

Estradiol treatment is noted to be a neuroprotective approach and may assist women with cyclical fluctuation in their BPD symptoms.

In this presentation, new approaches to the aetiology, possible preventative strategies and treatment of this prevalent and poorly understood psychiatric condition will be discussed

Bio: Jayashri KULKARNI commenced her appointment as Professor of Psychiatry, The Alfred and Monash University in 2002. She directs a large psychiatric research group, the Monash Alfred Psychiatry Research Centre (MAPrc), with approximately 150 staff and students. The Centre is dedicated to discovering new treatments, new understanding and new services for people with a range of mental illnesses.

Jayashri Kulkarni completed her MBBS degree in 1981 at Monash University and worked mainly in Emergency Medicine before deciding to specialise in Psychiatry. She became a Fellow of the Royal Australian and New Zealand College of Psychiatrists in 1989 and was awarded a PhD from Monash University in 1997 for her thesis “Women and Psychosis”. Jayashri has pioneered the novel use of estrogen as a treatment for schizophrenia and is internationally acknowledged as a leader in the field of reproductive hormones and their impact on mental health. Jayashri is the President of the International Association of Women’s Mental Health, a role she commenced in 2017.
... See moreSee less

Borderline Personality Disorder: A New Way Forward: MHPN 10th May 2017

Borderline Personality Disorder: A New Way Forward Borderline personality disorder (BPD) is a serious, often chronic and highly prevalent (5.9%) psychiatric ...

Posted 3 days ago

Hollie Wyber, Jess Hardy and 13 others like this

View previous comments

Mick WardI have bpd and bipolar who in queensland can i contact for help psychiatrists dont bulk bill3 days ago

Jennie Jones WalpoleFascinating research.....1   ·  3 days ago

Nikki RobertsLove your work 😎3 days ago

Nikki RobertsTalie Speed3 days ago

Tayla JordanSuzanne Jordan2 days ago

Comment on Facebook